EPITHERAPEUTICS
EpiTherapeutics is developing novel innovative cancer drugs based on epigenetics, a therapeutic area researched by renowned scientist Professor Kristian Helin and his group at Biotech Research & Innovation Centre (BRIC) at University of Copenhagen. EpiTherapeutics’ development programs are focused on enzymes involved in the regulation of transcription in cancer.
EPITHERAPEUTICS
Industry:
Biotechnology Medical
Founded:
1987-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.epitherapeutics.dk
Total Employee:
5001+
Status:
Active
Contact:
6505225696
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Current Advisors List
Founder
Investors List
Seed Capital
Seed Capital investment in Funding Round - Epitherapeutics
Novo Holdings
Novo Holdings investment in Funding Round - Epitherapeutics
Official Site Inspections
http://www.epitherapeutics.dk
- Host name: 22.167.207.35.bc.googleusercontent.com
- IP address: 35.207.167.22
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Epitherapeutics"
Epitherapeutics - Crunchbase Company Profile & Funding
Organization. Epitherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Foster City, California, United States; 5001-10000; …See details»
EpiTherapeutics - Genevia Technologies
EpiTherapeutics. Epitherapeutics was founded by Professor Kristian Helin and key members of his group at Biotech Research & Innovation Centre (BRIC) at University of Copenhagen. The …See details»
Gilead Sciences Acquires EpiTherapeutics
May 6, 2015 FOSTER CITY, Calif. & COPENHAGEN, Denmark--(BUSINESS WIRE)--May 6, 2015-- Gilead Sciences, Inc. (NASDAQ:GILD) and EpiTherapeutics ApS, a privately-held …See details»
EpiTherapeutics Company Profile 2024: Valuation, Investors
EpiTherapeutics was founded in 2008. Where is EpiTherapeutics headquartered? EpiTherapeutics is headquartered in Copenhagen, Denmark. What is the size of …See details»
Epitherapeutics ApS | 2100 Copenhagen, Capital Region of …
Oct 1, 2008 Epitherapeutics is a leading epigenetic drug discovery company with a focus on oncology and with several programs in lead optimization. Find investment information and …See details»
EpiTherapeutics - Products, Competitors, Financials, Employees ...
EpiTherapeutics is developing novel innovative cancer drugs based on the world leading research in epigenetics conducted by Professor Kristian Helin and his group at Biotech Research & …See details»
Biotech company founded at BRIC sold for 450 million DKK
EpiTherapeutics, a Danish firm that develops medicine using biomedical research conducted at the University of Copenhagen, was today sold to an American drug maker for 444 million …See details»
Gilead buys EpiTherapeutics to access Danish epigenetics expertise
May 7, 2015 Gilead Sciences has moved into epigenetic research by acquiring EpiTherapeutics for $65 million (€57 million) in cash. The deal gives it access to science originated at a team …See details»
Epitherapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Explore Epitherapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
EpiTherapeutics ApS: Drug pipelines, Patents, Clinical trials - Synapse
Explore EpiTherapeutics ApS with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»
EpiTherapeutics - VentureRadar
EpiTherapeutics is engaged in the development of novel innovative cancer drugs. EpiTherapeutics' development programs are focused on enzymes involved in the regulation of …See details»
EpiTherapeutics - The Lundbeck Foundation
EpiTherapeutics Discovery of new pharmaceuticals for the treatment of cancer within the field of epigenetics. Lundbeckfonden BioCapital. Invested. 2010 Acquired by Gilead in 2015. …See details»
EpiTherapeutics – Funding, Valuation, Investors, News | Parsers VC
EpiTherapeutics is a biopharmaceutical company developing novel innovative cancer drugs based on the world leading research in the field of epigenetics. EpiTherapeutics' development …See details»
New family of proteins led to DKK 500 million company
Science. New family of proteins led to DKK 500 million companySee details»
Et halvt år at løbe på | Ingeniøren
Mar 13, 2009 EpiTherapeutics er en nystartet dansk biotekvirksomhed, der forsker i at udvikle medicin til behandling af kræft. Virksomheden er igennem første investeringsrunde og skal …See details»
Gilead Sciences Acquires EpiTherapeutics - Technology Networks
May 7, 2015 “EpiTherapeutics has done groundbreaking work in a new therapeutic class of small molecule inhibitors with broad implications across various disease states,” said Martin …See details»
Epitherapeutics Receives Funding from Novo and SEED Capital …
The scientific discoveries of Epitherapeutics have potential applications in a wide range of clinical indications, but the company’s initial focus will be in oncology. Epitherapeutics' lead …See details»
Investments · northsea-therapeutics - Novo Holdings
Søren serves on the Board of Directors of EpiTherapeutics (sold to Gilead), AMRA, Biosyntia, Reapplix and Northsea Therapeutics. Since 2008, Søren has been board member of Danish …See details»
EpiTherapeutics approaches the clinic — MedWatch
Apr 22, 2015 EpiTherapeutics approaches the clinic. The deficit swelled in 2014 for the Danish-based biotech company EpiTherapeutics, which is now exploring options for additional …See details»
EpiTherapeutics-direktør: Flere tidlige salg — MedWatch
EpiTherapeutics-direktør: Flere tidlige salg. Der er penge nok i tanken til den fortsatte udvikling i biotekselskabet EpiTherapeutics. Spørgsmålet er, hvor hurtigt man skal satse på et salg eller …See details»